Chronic Hand Eczema, Real World, and Patient Centricity: A Narrative Review
DOI:
https://doi.org/10.2340/actadv.v105.42596Keywords:
allergic contact dermatitis, occupational contact dermatitis., chronic hand eczema, health related quality of lifeAbstract
Chronic hand eczema is a multifactorial, fluctuating, inflammatory skin disease of the hands and wrists, defined as hand eczema that persists for at least 3 months or recurs at least twice within 1 year. Chronic hand eczema is heterogeneous in nature with different clinical manifestations. This chronic condition can significantly impact daily activities and health-related quality of life for patients, including notable physical, psychosocial, occupational, and socioeconomic burdens. However, awareness of the disease and the patient experience remains poor. This review aims to improve understanding of chronic hand eczema in the context of its underlying pathogenesis, clinical subtypes and presentation, and risk factors. Additionally, an overview of the patient experience of the disease, including health-related quality of life and socioeconomic implications, is provided. Improved understanding of chronic hand eczema will support optimal patient care by empowering healthcare providers to more quickly and correctly diagnose this disease with high unmet treatment needs and subsequently offer appropriate holistic care.
Downloads
References
Thyssen JP, Schuttelaar MLA, Alfonso JH, Andersen KE, Angelova-Fischer I, Arents BWM, et al. Guidelines for diagnosis, prevention, and treatment of hand eczema. Contact Dermatitis 2022; 86: 357–378.
https://doi.org/10.1111/cod.14035 DOI: https://doi.org/10.1111/cod.14035
Quaade AS, Alinaghi F, Dietz JB, Erichsen CY, Johansen JD. Chronic hand eczema: a prevalent disease in the general population associated with reduced quality of life and poor overall health measures. Contact Dermatitis 2023; 89: 453–463.
https://doi.org/10.1111/cod.14407 DOI: https://doi.org/10.1111/cod.14407
Weidinger S, Novak N. Hand eczema. Lancet 2024; 404: 2476–2486.
https://doi.org/10.1016/S0140-6736(24)01810-5 DOI: https://doi.org/10.1016/S0140-6736(24)01810-5
Thyssen JP, Silverberg JI, Guttman-Yassky E. Chronic hand eczema understanding has ramifications on clinical management. J Eur Acad Dermatol Venereol 2020; 34: e429–e430.
https://doi.org/10.1111/jdv.16375 DOI: https://doi.org/10.1111/jdv.16375
Apfelbacher CJ, Ofenloch RF, Weisshaar E, Molin S, Bauer A, Mahler V, et al. Chronic hand eczema in Germany: 5-year follow-up data from the CARPE registry. Contact Dermatitis 2019; 80: 45–53.
https://doi.org/10.1111/cod.13113 DOI: https://doi.org/10.1111/cod.13113
Quaade AS, Simonsen AB, Halling AS, Thyssen JP, Johansen JD. Prevalence, incidence, and severity of hand eczema in the general population: a systematic review and meta-analysis. Contact Dermatitis 2021; 84: 361–374.
https://doi.org/10.1111/cod.13804 DOI: https://doi.org/10.1111/cod.13804
Dubin C, Del Duca E, Guttman-Yassky E. Drugs for the treatment of chronic hand eczema: successes and key challenges. Ther Clin Risk Manag 2020; 16: 1319–1332.
https://doi.org/10.2147/TCRM.S292504 DOI: https://doi.org/10.2147/TCRM.S292504
Grant L, Seiding Larsen L, Burrows K, Belsito DV, Weisshaar E, Diepgen T, et al. Development of a conceptual model of chronic hand eczema (CHE) based on qualitative interviews with patients and expert dermatologists. Adv Ther 2020; 37: 692–706.
https://doi.org/10.1007/s12325-019-01164-5 DOI: https://doi.org/10.1007/s12325-019-01164-5
Lee GR, Maarouf M, Hendricks AK, Lee DE, Shi VY. Current and emerging therapies for hand eczema. Dermatol Ther 2019; 32: e12840.
https://doi.org/10.1111/dth.12840 DOI: https://doi.org/10.1111/dth.12840
Quaade AS, Wang X, Sølberg JBK, McCauley BD, Thyssen JP, Becker C, et al. Inflammatory plasma signature of chronic hand eczema: associations with aetiological and clinical subtypes. J Eur Acad Dermatol Venereol 2024; 38: 1101–1111.
https://doi.org/10.1111/jdv.19742 DOI: https://doi.org/10.1111/jdv.19742
Quaade AS, Wang X, Sølberg JBK, Ulrich NH, McCauley BD, Thyssen JP, et al. Circulating biomarkers are associated with disease severity of chronic hand eczema and atopic dermatitis. Br J Dermatol 2023; 189: 114–124.
https://doi.org/10.1093/bjd/ljad110 DOI: https://doi.org/10.1093/bjd/ljad110
Tancredi V, Buononato D, Caccavale S, Di Brizzi EV, Di Caprio R, Argenziano G, et al. New perspectives in the management of chronic hand eczema: lessons from pathogenesis. Int J Mol Sci 2023; 25: 362.
https://doi.org/10.3390/ijms25010362 DOI: https://doi.org/10.3390/ijms25010362
Pedersen MB, Skov L, Menné T, Johansen JD, Olsen J. Gene expression time course in the human skin during elicitation of allergic contact dermatitis. J Invest Dermatol 2007; 127: 2585–2595.
https://doi.org/10.1038/sj.jid.5700902 DOI: https://doi.org/10.1038/sj.jid.5700902
Rosenberg FM, Wardenaar R, Voorberg AN, Spierings DCJ, Schuttelaar MA. Transcriptional differences between vesicular hand eczema and atopic dermatitis. Contact Dermatitis 2024; 90: 23–31.
https://doi.org/10.1111/cod.14442 DOI: https://doi.org/10.1111/cod.14442
Silverberg JI, Guttman-Yassky E, Agner T, Bissonnette R, Cohen DE, Simpson E, et al. Chronic hand eczema guidelines from an expert panel of the International Eczema Council. Dermatitis 2021; 32: 319–326.
https://doi.org/10.1097/DER.0000000000000659 DOI: https://doi.org/10.1097/DER.0000000000000659
Agner T, Aalto-Korte K, Andersen KE, Foti C, Gimenéz-Arnau A, Goncalo M, et al. Classification of hand eczema. J Eur Acad Dermatol Venereol 2015; 29: 2417–2422.
https://doi.org/10.1111/jdv.13308 DOI: https://doi.org/10.1111/jdv.13308
Gimenez-Arnau AM, Pesque D, Maibach HI. Contact urticaria syndrome: a comprehensive review. Curr Dermatol Rep 2022; 11: 194–201.
https://doi.org/10.1007/s13671-022-00379-0 DOI: https://doi.org/10.1007/s13671-022-00379-0
Agner T, Aalto-Korte K, Andersen KE, Foti C, Gimenéz-Arnau A, Goncalo M, et al. Factors associated with combined hand and foot eczema. J Eur Acad Dermatol Venereol 2017; 31: 828–832.
https://doi.org/10.1111/jdv.14016 DOI: https://doi.org/10.1111/jdv.14016
Petersen AH, Johansen JD, Hald M. Hand eczema – prognosis and consequences: a 7-year follow-up study. Br J Dermatol 2014; 171: 1428–1433.
https://doi.org/10.1111/bjd.13371 DOI: https://doi.org/10.1111/bjd.13371
Bertoli MJ, Schwartz RA, Janniger CK. Autoeczematization: a strange id reaction of the skin. Cutis 2021; 108: 163–166.
https://doi.org/10.12788/cutis.0342 DOI: https://doi.org/10.12788/cutis.0342
Heede NG, Thyssen JP, Thuesen BH, Linneberg A, Johansen JD. Predictive factors of self-reported hand eczema in adult Danes: a population-based cohort study with 5-year follow-up. Br J Dermatol 2016; 175: 287–295.
https://doi.org/10.1111/bjd.14476 DOI: https://doi.org/10.1111/bjd.14476
Grönhagen C, Lidén C, Wahlgren CF, Ballardini N, Bergström A, Kull I, et al. Hand eczema and atopic dermatitis in adolescents: a prospective cohort study from the BAMSE project. Br J Dermatol 2015; 173: 1175–1182.
https://doi.org/10.1111/bjd.14019 DOI: https://doi.org/10.1111/bjd.14019
Ruff SMD, Engebretsen KA, Zachariae C, Johansen JD, Silverberg JI, Egeberg A, et al. The association between atopic dermatitis and hand eczema: a systematic review and meta-analysis. Br J Dermatol 2018; 178: 879–888.
https://doi.org/10.1111/bjd.16147 DOI: https://doi.org/10.1111/bjd.16147
Apfelbacher C, Bewley A, Molin S, Fargnoli MC, Gimenez-Arnau AM, Brignoli L, et al. Prevalence of chronic hand eczema in adults: a cross-sectional survey of over 60,000 respondents in the general population in Canada, France, Germany, Italy, Spain, and the United Kingdom. Br J Dermatol 2025 Jan 11 [Online ahead of print].
https://doi.org/10.1093/bjd/ljaf020 DOI: https://doi.org/10.1093/bjd/ljaf020
Lund T, Petersen SB, Flachs EM, Ebbehøj NE, Bonde JP, Agner T. Risk of work-related hand eczema in relation to wet work exposure. Scand J Work Environ Health 2020; 46: 437–445.
https://doi.org/10.5271/sjweh.3876 DOI: https://doi.org/10.5271/sjweh.3876
Lerbaek A, Kyvik KO, Mortensen J, Bryld LE, Menné T, Agner T. Heritability of hand eczema is not explained by comorbidity with atopic dermatitis. J Invest Dermatol 2007; 127: 1632–1640.
https://doi.org/10.1038/sj.jid.5700750 DOI: https://doi.org/10.1038/sj.jid.5700750
Heede NG, Thyssen JP, Thuesen BH, Linneberg A, Johansen JD. Anatomical patterns of dermatitis in adult filaggrin mutation carriers. J Am Acad Dermatol 2015; 72: 440–448.
https://doi.org/10.1016/j.jaad.2015.01.001 DOI: https://doi.org/10.1016/j.jaad.2015.01.001
Dalgard FJ, Gieler U, Tomas-Aragones L, Lien L, Poot F, Jemec GBE, et al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol 2015; 135: 984–991.
https://doi.org/10.1038/jid.2014.530 DOI: https://doi.org/10.1038/jid.2014.530
Ahmed A, Shah R, Papadopoulos L, Bewley A. An ethnographic study into the psychological impact and adaptive mechanisms of living with hand eczema. Clin Exp Dermatol 2015; 40: 495–501.
https://doi.org/10.1111/ced.12619 DOI: https://doi.org/10.1111/ced.12619
Armstrong A, Hahn-Pedersen J, Bartlett C, Glanville J, Thyssen JP. Economic burden of chronic hand eczema: a review. Am J Clin Dermatol 2022; 23: 287–300.
https://doi.org/10.1007/s40257-021-00669-6 DOI: https://doi.org/10.1007/s40257-021-00669-6
Oosterhaven JAF, Flach PA, Bültmann U, Schuttelaar MLA. Presenteeism in a Dutch hand eczema population: a cross-sectional survey. Contact Dermatitis 2018; 79: 10–19.
https://doi.org/10.1111/cod.12993 DOI: https://doi.org/10.1111/cod.12993
Fowler JF, Ghosh A, Sung J, Emani S, Chang J, Den E, et al. Impact of chronic hand dermatitis on quality of life, work productivity, activity impairment, and medical costs. J Am Acad Dermatol 2006; 54: 448–457.
https://doi.org/10.1016/j.jaad.2005.11.1053 DOI: https://doi.org/10.1016/j.jaad.2005.11.1053
Egeberg A, Schlapbach C, Haugaard JH, Nymand L, Thein D, Thomsen SF, et al. Adverse events from topical corticosteroid use in chronic hand eczema: findings from the Danish Skin Cohort. JAAD Int 2024; 14: 77–83.
https://doi.org/10.1016/j.jdin.2023.11.004 DOI: https://doi.org/10.1016/j.jdin.2023.11.004
Scalone L, Cortesi PA, Mantovani LG, Belisari A, Ayala F, Fortina AB, et al. Clinical epidemiology of hand eczema in patients accessing dermatological reference centres: results from Italy. Br J Dermatol 2015; 172: 187–195.
https://doi.org/10.1111/bjd.13220 DOI: https://doi.org/10.1111/bjd.13220
Christoffers WA, Politiek K, Coenraads PJ, van der Schaft J, de Bruin-Weller MS, Schuttelaar ML. Drug survival of cyclosporine in the treatment of hand eczema: a multicentre, daily use study. J Eur Acad Dermatol Venereol 2016; 30: 63–66.
https://doi.org/10.1111/jdv.13057 DOI: https://doi.org/10.1111/jdv.13057
Oosterhaven JAF, Politiek K, Schuttelaar M-LA. Azathioprine treatment and drug survival in patients with chronic hand eczema: results from daily practice. Contact Dermatitis 2017; 76: 304–307.
https://doi.org/10.1111/cod.12691 DOI: https://doi.org/10.1111/cod.12691
Politiek K, Christoffers WA, Coenraads PJ, Schuttelaar MA. Alitretinoin and acitretin in severe chronic hand eczema: results from a retrospective daily practice study. Dermatol Ther 2016; 29: 364–371.
https://doi.org/10.1111/dth.12362 DOI: https://doi.org/10.1111/dth.12362
Politiek K, van der Schaft J, Christoffers WA, Coenraads PJ, van den Reek JM, de Jong EM, et al. Drug survival of methotrexate treatment in hand eczema patients: results from a retrospective daily practice study. J Eur Acad Dermatol Venereol 2016; 30: 1405–1407.
https://doi.org/10.1111/jdv.13253 DOI: https://doi.org/10.1111/jdv.13253
Ho JSS, Molin S. A review of existing and new treatments for the management of hand eczema. J Cutan Med Surg 2023; 27: 493–503.
https://doi.org/10.1177/12034754231188325 DOI: https://doi.org/10.1177/12034754231188325
European Medicines Agency. Anzupgo: EPAR – Product information [accessed 24 March 2024]. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/anzupgo.
Published
How to Cite
License
Copyright (c) 2025 Sonja Molin, Emma Guttman-Yassky, Jacob P. Thyssen, Anthony Bewley
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
